Jiangsu Hengrui Pharmaceuticals Co.,Ltd

DB:0BO Stock Report

Market Cap: €50.0b

Jiangsu Hengrui PharmaceuticalsLtd Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:0BO Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
04 Nov 25Buy€6,956,077Wellington Management Group LLPCompany855,600€8.13
03 Nov 25Buy€509,123JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany62,048€8.21
03 Nov 25Sell€2,894,831JP Morgan Asset ManagementCompany352,800€8.21
31 Oct 25Sell€7,519,788JP Morgan Asset ManagementCompany898,800€8.37
31 Oct 25Sell€13,940,916JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany1,666,283€8.37
30 Oct 25Buy€8,298,275Wellington Management Group LLPCompany1,012,231€8.20
30 Oct 25Buy€3,514,387GIC Private LimitedCompany430,000€8.17
30 Oct 25Buy€51,296,756JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany6,263,934€8.19
28 Oct 25Sell€10,653,773JP Morgan Asset ManagementCompany1,269,782€8.39
16 Oct 25Sell€27,904,937JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany3,058,387€9.12
13 Oct 25Buy€4,472,144GIC Private LimitedCompany486,200€9.20
09 Oct 25Sell€4,421,797JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany452,179€9.78
26 Sep 25Buy€11,098,995JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany1,161,565€9.56
23 Sep 25Sell€13,677,585JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany1,430,392€9.56
19 Sep 25Buy€16,519,431Capital Research and Management CompanyCompany1,728,200€9.56
15 Sep 25Sell€4,824,411UBS Asset Management AGCompany546,400€8.83
11 Sep 25Buy€22,573,633GIC Private LimitedCompany2,519,000€8.96
11 Sep 25Sell€40,749,895JP Morgan Asset ManagementCompany4,653,630€8.76
08 Sep 25Buy€1,917,350UBS Asset Management AGCompany204,400€9.38
05 Sep 25Sell€5,490,965JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany595,961€9.21
05 Sep 25Sell€6,925,745UBS Asset Management AGCompany741,150€9.34
03 Sep 25Buy€29,695,448JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany3,164,599€9.38
29 Aug 25Buy€23,214,488JP Morgan Asset ManagementCompany2,811,336€8.26
19 Aug 25Sell€5,369,153JP Morgan Asset ManagementCompany607,153€8.84
19 Aug 25Sell€8,354,818UBS Asset Management AGCompany944,200€8.85
14 Aug 25Buy€27,645JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany3,200€8.64
14 Aug 25Buy€2,411,544JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany279,142€8.64
13 Aug 25Sell€12,287,011JP Morgan Asset ManagementCompany1,460,450€8.41
04 Aug 25Buy€15,778,506JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany1,859,201€8.49
04 Aug 25Sell€6,267,338UBS Asset Management AGCompany740,300€8.47
01 Aug 25Sell€2,141,799JP Morgan Asset ManagementCompany251,313€8.52
30 Jul 25Sell€9,695,993GIC Private LimitedCompany1,071,800€9.05
29 Jul 25Sell€18,782,508GIC Private LimitedCompany2,058,800€9.12
25 Jul 25Sell€8,461,187Capital Research and Management CompanyCompany1,119,200€7.56
22 Jul 25Sell€1,620,655Invesco Ltd.Company206,200€7.86
11 Jul 25Buy€9,251,479Wellington Management Group LLPCompany1,140,000€8.12
10 Jul 25Sell€1,294,046Wellington Management Group LLPCompany160,462€8.06
08 Jul 25Buy€15,214,563JP Morgan Asset ManagementCompany2,285,819€6.66
08 Jul 25Sell€10,621,318Invesco Ltd.Company1,590,600€6.68
08 Jul 25Sell€2,526,029UBS Asset Management AGCompany380,800€6.63
26 Jun 25Buy€2,213,319Wellington Management Group LLPCompany362,460€6.11
26 Jun 25Buy€1,951,266GIC Private LimitedCompany317,600€6.14
24 Jun 25Buy€1,319,227Wellington Management Group LLPCompany211,388€6.24
24 Jun 25Sell€1,736,466JP Morgan Asset ManagementCompany277,550€6.26
16 Jun 25Buy€9,217,857JP Morgan Asset ManagementCompany1,421,302€6.49
06 Jun 25Buy€1,622,198Wellington Management Group LLPCompany253,000€6.41
06 Jun 25Sell€11,950,741Invesco Ltd.Company1,863,000€6.41
04 Jun 25Sell€16,769,706Invesco Ltd.Company2,589,000€6.48
03 Jun 25Buy€1,216,963JP Morgan Asset ManagementCompany189,600€6.42
30 May 25Buy€16,781,402Morgan Stanley, Investment Banking and Brokerage InvestmentsCompany2,583,610€6.50
30 May 25Buy€1,521,086GIC Private LimitedCompany234,400€6.49
29 May 25Sell€2,062,037UBS Asset Management AGCompany335,720€6.14
29 May 25Sell€3,691,685JP Morgan Asset ManagementCompany582,600€6.34
28 May 25Buy€4,731,710JP Morgan Asset ManagementCompany746,000€6.34
28 May 25Sell€723,076JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany114,000€6.34
27 May 25Buy€2,043,184JP Morgan Asset ManagementCompany330,313€6.19
23 May 25Buy€108,917,650Capital Research and Management CompanyCompany19,749,200€5.52
23 May 25Buy€48,253,602JP Morgan Asset ManagementCompany7,470,232€6.46
23 May 25Buy€10,744,477JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany1,663,373€6.46
23 May 25Buy€130,961,216Invesco Ltd.Company26,390,400€4.96

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 0BO?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders7,843,0540.118%
Employee Share Scheme35,700,0000.539%
Institutions1,728,427,77626.1%
General Public1,968,820,67829.7%
Private Companies2,884,149,25643.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 64.89% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
23.2%
Jiangsu Hengrui Medicine Group Co., Ltd.
1,538,184,187€11.6b0%no data
14.4%
Tibet Dagze Huixin Investment Management Partnership (Limited Partnership)
952,752,304€7.2b0%no data
5.88%
Hong Kong Exchanges and Clearing Limited
389,525,860€2.9b0%3.29%
3.09%
China National Pharmaceutical Group Corporation
204,669,209€1.5b-8.2%no data
2.74%
Qingdao Bosentai Investment Partnership Enterprise (Limited Partnership)
181,506,156€1.4b-0.18%no data
1.66%
Lianyungang Financial Holding Group Co., Ltd.
109,787,876€828.9m-1.81%no data
1.44%
China Securities Finance Corporation Limited
95,399,822€720.3m0%0.89%
1.36%
China Universal Asset Management Company Ltd.
90,311,019€681.8m-0.03%1.92%
1.32%
China Asset Management Co. Ltd.
87,616,096€661.5m7.2%0.6%
1.2%
Huatai-PineBridge Fund Management Co., Ltd.
79,499,531€600.2m3.17%1.0%
1.19%
E Fund Management Co., Ltd.
79,036,142€596.7m0%0.52%
1.05%
Zhong Ou Fund Management Co., Ltd
69,779,796€526.8m0%1.9%
0.97%
ICBC Credit Suisse Fund Management Co., Ltd
64,049,049€483.6m0%2.33%
0.82%
GIC Private Limited
54,422,600€410.9m5.31%0.8%
0.65%
Harvest Fund Management Co. Ltd.
42,808,327€323.2m0%0.55%
0.63%
Capital Research and Management Company
41,464,135€313.1m-6.25%0.02%
0.54%
Jiangsu Hengrui Medicine Co., Ltd., ESOP
35,700,000€269.5m0%no data
0.48%
GF Fund Management Co., Ltd.
31,607,702€238.6m0%0.43%
0.45%
Yinhua Fund Management Co., Ltd.
29,784,230€224.9m-0.25%1.39%
0.39%
BlackRock, Inc.
25,989,755€196.2m13.2%no data
0.31%
Guotai Asset Management Company Limited
20,586,279€155.4m-0.03%0.57%
0.31%
HuaAn Fund Management Company Ltd.
20,396,227€154.0m0%0.55%
0.29%
Wellington Management Group LLP
19,012,140€143.5m38.9%0.03%
0.28%
The Vanguard Group, Inc.
18,233,683€137.7m1.89%no data
0.25%
Penghua Fund Management Co., Ltd.
16,730,232€126.3m0%0.66%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/12 23:51
End of Day Share Price 2025/11/12 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Jiangsu Hengrui Pharmaceuticals Co.,Ltd is covered by 46 analysts. 25 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bo LiBofA Global Research
Yanan HouBohai Securities Co., Ltd.
Shun Kei LawCCB International Securities Limited